{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:12:15Z","timestamp":1787508735583,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sport et Collection"},{"DOI":"10.13039\/501100004099","name":"La Ligue Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"France-ADOT86"},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jconrel.2017.11.011","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T21:47:05Z","timestamp":1510264025000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor \u03b1 expression induced by dexamethasone and valproic acid"],"prefix":"10.1016","volume":"269","author":[{"given":"E.","family":"P\u00e9raudeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cronier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Monvoisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Poinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mergault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guilhot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Tranoy-Opalinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Renoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Papot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Clarhaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.11.011_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0010","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/anie.201307628","article-title":"Antibody-drug conjugates: an emerging concept in cancer therapy","volume":"53","author":"Chari","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nbt.2289","article-title":"The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma","volume":"30","author":"Senter","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0030","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0035","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/anie.201204631","article-title":"Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries","volume":"52","author":"Krall","year":"2013","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0040","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1021\/acs.jmedchem.5b00457","article-title":"Antibody-drug conjugates and small molecule-drug conjugates: opportunities and challenges for the development of selective anticancer cytotoxic agents","volume":"58","author":"Casi","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21712","article-title":"The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?","volume":"119","author":"Kelemen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-007-9048-0","article-title":"The folate receptor: what does it promise in tissue-targeted therapeutics?","volume":"26","author":"Salazar","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425247.2012.694863","article-title":"Clinical translation of folate receptor-targeted therapeutics","volume":"9","author":"Teng","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/JTO.0b013e31824de09c","article-title":"High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation","volume":"7","author":"Nunez","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13402-011-0052-6","article-title":"The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer","volume":"35","author":"Crane","year":"2012","journal-title":"Cell. Oncol. Dordr."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.18632\/oncotarget.519","article-title":"Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance","volume":"3","author":"O'Shannessy","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JTO.0b013e31827628ff","article-title":"Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed","volume":"8","author":"Christoph","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-014-9539-8","article-title":"Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications","volume":"34","author":"Vergote","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acs.molpharmaceut.5b00575","article-title":"Efficient and tumor targeted siRNA delivery by polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol)","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0100","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/bm100338x","article-title":"Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake","volume":"11","author":"Barz","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0105","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/acs.bioconjchem.7b00383","article-title":"Systemic delivery of folate-PEG siRNA lipopolyplexes with enhanced intracellular stability for in vivo gene silencing in leukemia","volume":"28","author":"Lee","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0110","first-page":"7442","article-title":"Microfluidic self-assembly of folate-targeted monomolecular siRNA-lipid nanoparticles","volume":"9","author":"Krzyszto\u0144","year":"2017","journal-title":"Nano"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0115","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1021\/jm100509v","article-title":"Folate-targeted therapies for cancer","volume":"53","author":"Xia","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/acs.bioconjchem.5b00545","article-title":"In vitro and in vivo tumor-targeting siRNA delivery using folate-PEG-appended dendrimer (G4)\/\u03b1-cyclodextrin conjugates","volume":"27","author":"Ohyama","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biomaterials.2015.11.004","article-title":"Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand","volume":"77","author":"Lee","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0130","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1158\/0008-5472.CAN-07-0033","article-title":"Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate","volume":"67","author":"Reddy","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0135","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bc2005522","article-title":"Engineering folate-drug conjugates to target cancer: from chemistry to clinic","volume":"23","author":"Vlahov","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1758834015584763","article-title":"Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors","volume":"7","author":"Vergote","year":"2015","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0145","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/annonc\/mdu024","article-title":"Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)","volume":"25","author":"Morris","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/17425247.5.3.309","article-title":"Targeted drug delivery via folate receptors","volume":"5","author":"Zhao","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/cmdc.201100114","article-title":"A galactosidase-responsive \u201ctrojan horse\u201d for the selective targeting of folate receptor-positive tumor cells","volume":"6","author":"Thomas","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0160","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1002\/anie.201204935","article-title":"The first generation of \u03b2-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy","volume":"51","author":"Legigan","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0165","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.leukres.2013.04.026","article-title":"A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts","volume":"37","author":"Clarhaut","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0170","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1039\/c3ob41536h","article-title":"An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process","volume":"11","author":"Grinda","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0180","doi-asserted-by":"crossref","first-page":"15792","DOI":"10.1039\/C5CC05294G","article-title":"A dendritic \u03b2-galactosidase-responsive folate-monomethylauristatin E conjugate","volume":"51","author":"Alsarraf","year":"2015","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0185","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-04-2890","article-title":"Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting","volume":"65","author":"Tran","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2013.03.032","article-title":"Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone","volume":"448","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/273345a0","article-title":"Role of cell shape in growth control","volume":"273","author":"Folkman","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/jpet.106.110957","article-title":"Microtubule-destabilizing agents induce focal adhesion structure disorganization and anoikis in cancer cells","volume":"320","author":"Deschesnes","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2015.04.019","article-title":"Anti-tumor activity of staurosporine in the tumor microenvironment of cervical cancer: an in vitro study","volume":"133","author":"Yadav","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0955-0674(00)00251-9","article-title":"Anoikis mechanisms","volume":"13","author":"Frisch","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0215","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0220","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nbt832","article-title":"Development of potent monoclonal antibody auristatin conjugates for cancer therapy","volume":"21","author":"Doronina","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2014.06.051","article-title":"Cationic lipid-conjugated dexamethasone as a selective antitumor agent","volume":"83","author":"Sau","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0230","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4238\/2014.August.29.4","article-title":"Inhibitory effect of dexamethasone on Lewis mice lung cancer cells","volume":"13","author":"Geng","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00404-013-2762-7","article-title":"Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II","volume":"288","author":"Tsai","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08982100801893978","article-title":"Utility of targeted glucocorticoids in cancer therapy","volume":"18","author":"Banciu","year":"2008","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0245","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.108.143206","article-title":"Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates","volume":"327","author":"Leamon","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.rvsc.2012.07.018","article-title":"Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity","volume":"94","author":"Qin","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0260","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jbspin.2012.12.001","article-title":"Side effects of corticosteroid injections: what's new?","volume":"80","author":"Berthelot","year":"2013","journal-title":"Jt. Bone Spine Rev. Rhum."},{"key":"10.1016\/j.jconrel.2017.11.011_bb0270","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1182\/blood-2012-05-429183","article-title":"The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner","volume":"120","author":"Fraineau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.11.011_bb0275","first-page":"e51998","article-title":"The soft agar colony formation assay","author":"Borowicz","year":"2014","journal-title":"J. Vis. Exp."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:37:33Z","timestamp":1537850253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917310003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":55,"alternative-id":["S0168365917310003"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor \u03b1 expression induced by dexamethasone and valproic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}